Nerve growth factor administration attenuates cognitive but not neurobehavioral motor dysfunction or hippocampal cell loss following fluid-percussion brain injury in rats.
Lateral fluid-percussion brain injury in rats results in cognitive deficits, motor dysfunction, and selective hippocampal cell loss. Neurotrophic factors have been shown to have potential therapeutic applications in neurodegenerative diseases, and nerve growth factor (NGF) has been shown to be neuroprotective in models of excitotoxicity. This study evaluated the neuroprotective efficacy of intracerebral NGF infusion after traumatic brain injury. Male Sprague-Dawley rats received lateral fluid-percussion brain injury of moderate severity (2.1-2.3 atm). A miniosmotic pump was implanted 24 h after injury to infuse NGF (n = 34) or vehicle (n = 16) directly into the region of maximal cortical injury. Infusions of NGF continued until the animal was killed at 72 h, 1 week, or 2 weeks after injury. Animals were evaluated for cognitive dysfunction (Morris Water Maze) and regional neuronal cell loss (Nissl staining) at each of the three time points. Animals surviving for 1 or 2 weeks were also evaluated for neurobehavioral motor function. Although an improvement in memory scores was not observed at 72 h after injury, animals receiving NGF infusions showed significantly improved memory scores when tested at 1 or 2 weeks after injury compared with injured animals receiving vehicle infusions (p < 0.05). Motor scores and CA3 hippocampal cell loss were not significantly different in any group of NGF-treated animals when compared with controls. These data suggest that NGF administration, in the acute, posttraumatic period following fluid-percussion brain injury, may have potential in improving post-traumatic cognitive deficits.
Sinson
G
G
Division of Neurosurgery, University of Pennsylvania School of Medicine, Philadelphia 19104-4283, USA.
Voddi
M
M
McIntosh
T K
TK
D000818:Animals; D001930:Brain Injuries / Q000209:etiology / Q000473:pathology / Q000503:physiopathology* / Q000523:psychology*; D016923:Cell Death / Q000187:drug effects; D003071:Cognition / Q000187:drug effects*; D006624:Hippocampus / Q000473:pathology*; D008297:Male; D009069:Movement Disorders / Q000503:physiopathology*; D009414:Nerve Growth Factors / Q000494:pharmacology*; D010474:Percussion; D051381:Rats; D017207:Rats, Sprague-Dawley
D009414:Nerve Growth Factors